{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:06:40Z","timestamp":1790917600241,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.bcp.2005.11.008","type":"journal-article","created":{"date-parts":[[2005,12,7]],"date-time":"2005-12-07T13:36:55Z","timestamp":1133962615000},"page":"486-496","source":"Crossref","is-referenced-by-count":31,"title":["Modulation of intestinal barrier properties by miltefosine"],"prefix":"10.1016","volume":"71","author":[{"given":"C\u00e9cile","family":"Menez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Buyse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Chacun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Farinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Barratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2005.11.008_bib1","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/318122","article-title":"Short-course of oral miltefosine for treatment of visceral leishmaniasis","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bcp.2005.11.008_bib2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda","volume":"2","author":"Guerin","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2005.11.008_bib3","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/BF02535537","article-title":"Accumulation of an alkyl lysophospholipid in tumor cell membranes affects membrane fluidity and tumor cell invasion","volume":"22","author":"Van Blitterswijk","year":"1987","journal-title":"Lipids"},{"key":"10.1016\/j.bcp.2005.11.008_bib4","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/0959-8049(95)00350-9","article-title":"Effects of hexadecylphosphocholine on membrane phospholipid metabolism in human tumour cells","volume":"31A","author":"Berkovic","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bcp.2005.11.008_bib5","first-page":"27","article-title":"Alkylphospholipids reversibly open epithelial tight junctions","volume":"23","author":"Leroy","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bcp.2005.11.008_bib6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1124\/jpet.102.043638","article-title":"Role of phospholipase C-beta in the modulation of epithelial tight junction permeability","volume":"304","author":"Ward","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2005.11.008_bib7","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1021\/js990094e","article-title":"Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers","volume":"88","author":"Liu","year":"1999","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.bcp.2005.11.008_bib8","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1021\/js9900957","article-title":"Structure\u2013activity relationships for enhancement of paracellular permeability by 2-alkoxy-3-alkylamidopropylphosphocholines across Caco-2 cell monolayers","volume":"88","author":"Liu","year":"1999","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.bcp.2005.11.008_bib9","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1021\/jm020001x","article-title":"Structure\u2013activity relationship for enhancement of paracellular permeability across Caco-2 cell monolayers by 3-alkylamido-2-alkoxypropylphosphocholines","volume":"45","author":"Ouyang","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2005.11.008_bib10","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1023\/A:1016225707807","article-title":"Drug delivery studies in Caco-2 monolayers IV. Absorption enhancer effects of cyclodextrins","volume":"12","author":"Hovgaard","year":"1995","journal-title":"Pharm Res"},{"key":"10.1016\/j.bcp.2005.11.008_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1464-5491.1992.tb01792.x","article-title":"Intranasal administration of insulin with phospholipid as absorption enhancer: pharmacokinetics in normal subjects","volume":"9","author":"Drejer","year":"1992","journal-title":"Diabet Med"},{"key":"10.1016\/j.bcp.2005.11.008_bib12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1461-5347(00)00302-3","article-title":"Enhancing paracellular permeability by modulating epithelial tight junctions","volume":"3","author":"Ward","year":"2000","journal-title":"Pharm Sci Technol Today"},{"key":"10.1016\/j.bcp.2005.11.008_bib13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1471-4159.1997.68030991.x","article-title":"Lysophosphatidic acid increases tight junction permeability in cultured brain endothelial cells","volume":"68","author":"Schulze","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2005.11.008_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0378-5173(94)00233-U","article-title":"Drug delivery studies in Caco-2 monolayers III. Intestinal transport of various vasopressin analogues in the presence of lysophosphatidylcholine","volume":"114","author":"Brondsted","year":"1995","journal-title":"Int J Pharm"},{"key":"10.1016\/j.bcp.2005.11.008_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1248\/bpb.22.103","article-title":"Modification of ceftibuten transport by changes in lipid fluidity caused by fatty acid glycerol esters","volume":"22","author":"Koga","year":"1999","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.bcp.2005.11.008_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0928-0987(02)00055-6","article-title":"Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers","volume":"16","author":"Rege","year":"2002","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.bcp.2005.11.008_bib17","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1023\/A:1016033702220","article-title":"The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system","volume":"13","author":"Nerurkar","year":"1996","journal-title":"Pharm Res"},{"key":"10.1016\/j.bcp.2005.11.008_bib18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jps.2600790604","article-title":"Epithelial transport of drugs in cell culture I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells","volume":"79","author":"Artursson","year":"1990","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.bcp.2005.11.008_bib19","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0016-5085(89)80072-1","article-title":"Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability","volume":"96","author":"Hidalgo","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2005.11.008_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.bcp.2005.11.008_bib21","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1023\/A:1018903931777","article-title":"Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments","volume":"10","author":"Artursson","year":"1993","journal-title":"Pharm Res"},{"key":"10.1016\/j.bcp.2005.11.008_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0378-5173(02)00588-4","article-title":"Effects of citicholine and dimethylsulfoxide on transepithelial transport of passively diffused drugs in the Caco-2 cell culture model","volume":"251","author":"Demirbas","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1016\/j.bcp.2005.11.008_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1056-8719(01)00161-7","article-title":"Optimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysis","volume":"46","author":"Markowska","year":"2001","journal-title":"J Pharm Tox Methods"},{"key":"10.1016\/j.bcp.2005.11.008_bib24","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1242\/jcs.113.10.1771","article-title":"Tight junctions are membrane microdomains","volume":"113","author":"Nusrat","year":"2000","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bcp.2005.11.008_bib25","doi-asserted-by":"crossref","first-page":"G775","DOI":"10.1152\/ajpgi.2000.279.4.G775","article-title":"Mechanism(s) of butyrate transport in Caco-2 cells: role of monocarboxylate transporter 1","volume":"279","author":"Hadjiagapiou","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.bcp.2005.11.008_bib26","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1476-5381.1994.tb17099.x","article-title":"Substrate specificity of the di\/tripeptide transporter in human intestinal epithelia (Caco-2): identification of substrates that undergo H(+)-coupled absorption","volume":"113","author":"Thwaites","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2005.11.008_bib27","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1476-5381.1996.tb15550.x","article-title":"Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells","volume":"118","author":"Cavet","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2005.11.008_bib28","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(98)04367-0","article-title":"Trial of oral miltefosine for visceral leishmaniasis","volume":"352","author":"Sundar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2005.11.008_bib29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0924-8579(03)00125-0","article-title":"Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine)","volume":"22","author":"Seifert","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bcp.2005.11.008_bib30","doi-asserted-by":"crossref","first-page":"11414","DOI":"10.1021\/la040036v","article-title":"Surface behavior of oleoyl palmitoyl phosphatidyl ethanolamine (OPPE) and the characteristics of mixed OPPE-miltefosine monolayers","volume":"20","author":"Rey Gomez-Serranillos","year":"2004","journal-title":"Langmuir"},{"key":"10.1016\/j.bcp.2005.11.008_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1359-4117.2003.01094.x","article-title":"Effects of etherlipid analogs on cell membrane functions","volume":"3","author":"Berkovic","year":"2003","journal-title":"J Exp Ther Oncol"},{"key":"10.1016\/j.bcp.2005.11.008_bib32","first-page":"2835","article-title":"Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues","volume":"52","author":"Powis","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2005.11.008_bib33","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0006-2952(99)00288-9","article-title":"Mechanism of inhibition of P-glycoprotein-mediated drug transport by protein kinase C blockers","volume":"58","author":"Castro","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2005.11.008_bib34","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0006-2952(97)00095-6","article-title":"Differential regulation of phospholipase A2 in human leukemia cells by the etherphospholipid analogue hexadecylphosphocholine","volume":"53","author":"Berkovic","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2005.11.008_bib35","first-page":"807","article-title":"Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity","volume":"51","author":"Uberall","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2005.11.008_bib36","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0035-9203(00)90238-4","article-title":"Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in India","volume":"94","author":"Thakur","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.bcp.2005.11.008_bib37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1248\/bpb.28.316","article-title":"In vivo effects of cyclosporin A and ketoconazole on the pharmacokinetics of representative substrates for P-glycoprotein and cytochrome P450 (CYP) 3A in rats","volume":"28","author":"Kageyama","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.bcp.2005.11.008_bib38","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1124\/jpet.302.2.742","article-title":"Effect of interleukin-2 on intestinal P-glycoprotein expression and functionality in mice","volume":"302","author":"Veau","year":"2002","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295205007525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295205007525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T02:37:33Z","timestamp":1626835053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295205007525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0006295205007525"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2005.11.008","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}